Emoretcha, Jeolita A.
HRN: 21-47-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2022
CEFUROXIME 500MG (TAB)
06/23/2022
06/30/2022
PO
500mg
BID X 7 Days
Post-partum Prophylaxis, G4P4
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes